ghk-cu safety human studies for Hair Loss: Evidence, Safety, and UK Treatment Options – Bolt Pharmacy GHK-Cu – True Research Labs

It is also written as NAD plus injection or injection NAD

Do not use if you are allergic to any B-vitamin or any other ingredient in this product (may cause severe rash or breathing trouble)

Cleveland Clinic (2025) highlights investigational status, recommending standard care first

BPC-157 is a Specified Substance in the class of Non-Approved Substances and TB-500, CJC-1295, ipamorelin, and tesamorelin are nonSpecified Substances in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics

The combination uses therapeutic but conservative doses of each component, and the synergistic effects actually allow for lower individual peptide amounts than if using them separately

Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture